230 related articles for article (PubMed ID: 11920590)
1. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
Fiedler T; Walter W; Reichert TE; Maeurer MJ
Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice.
Chen YH; Wang B; Chun T; Zhao L; Cardell S; Behar SM; Brenner MB; Wang CR
J Immunol; 1999 Apr; 162(8):4560-6. PubMed ID: 10201995
[TBL] [Abstract][Full Text] [Related]
4. Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function.
Sundararaj S; Zhang J; Krovi SH; Bedel R; Tuttle KD; Veerapen N; Besra GS; Khandokar Y; Praveena T; Le Nours J; Matsuda JL; Rossjohn J; Gapin L
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1204-E1213. PubMed ID: 29351991
[TBL] [Abstract][Full Text] [Related]
5. Diverse TCRs recognize murine CD1.
Behar SM; Podrebarac TA; Roy CJ; Wang CR; Brenner MB
J Immunol; 1999 Jan; 162(1):161-7. PubMed ID: 9886382
[TBL] [Abstract][Full Text] [Related]
6. Presence of a novel subset of NKT cells bearing an invariant V(alpha)19.1-J(alpha)26 TCR alpha chain.
Shimamura M; Huang YY
FEBS Lett; 2002 Apr; 516(1-3):97-100. PubMed ID: 11959111
[TBL] [Abstract][Full Text] [Related]
7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
9. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L
Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo.
Renukaradhya GJ; Sriram V; Du W; Gervay-Hague J; Van Kaer L; Brutkiewicz RR
Int J Cancer; 2006 Jun; 118(12):3045-53. PubMed ID: 16395717
[TBL] [Abstract][Full Text] [Related]
11. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis.
Campos-Martín Y; Gómez del Moral M; Gozalbo-López B; Suela J; Martínez-Naves E
J Immunol; 2004 Jun; 172(12):7297-305. PubMed ID: 15187105
[TBL] [Abstract][Full Text] [Related]
12. CD1 antigen presentation and infectious disease.
Dascher CC; Brenner MB
Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
[TBL] [Abstract][Full Text] [Related]
13. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
14. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
15. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
16. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments.
Chiu YH; Jayawardena J; Weiss A; Lee D; Park SH; Dautry-Varsat A; Bendelac A
J Exp Med; 1999 Jan; 189(1):103-10. PubMed ID: 9874567
[TBL] [Abstract][Full Text] [Related]
17. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1.
Huang MM; Borszcz P; Sidobre S; Kronenberg M; Kane KP
J Immunol; 2004 May; 172(9):5304-12. PubMed ID: 15100269
[TBL] [Abstract][Full Text] [Related]
18. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
19. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
20. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.
Mempel M; Ronet C; Suarez F; Gilleron M; Puzo G; Van Kaer L; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2002 Jan; 168(1):365-71. PubMed ID: 11751982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
